Print Page

其 他 安 全 警 示

 
FDA requires boxed warning for promethazine hydrochloride injection (English only)
 
FDA is requiring a boxed warning for promethazine hydrochloride injection products to better communicate the risks of severe tissue injury associated with intravenous administration of this drug. The relevant link for the news is: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm182500.htm

Situation in Hong Kong: There is no parenteral product of promethazine hydrochloride registered in Hong Kong.

Ends/Thursday, September 17, 2009
Issued at HKT 15:00
 
Related Information:
The United States: FDA requires updates to labeling for promethazine hydrochlori... 上载于 2023-12-28
 
back